Candriam Equities L Biotechnology, V - Capitalisation/ LU0317020203 /
| NAV2024-12-19 | Chg.-11.9500 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 2,077.2100USD | -0.57% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | - | - | - | 3.61 | 5.39 | -8.19 | 12.61 | -2.42 | 3.86 | -12.36 | 8.75 | -2.82 | - |
| 2017 | 5.51 | 6.90 | -0.08 | 1.23 | -3.06 | 9.25 | 2.56 | 6.40 | 0.81 | -6.34 | 0.29 | 1.54 | +26.78% |
| 2018 | 6.88 | -4.67 | -1.88 | -3.09 | 4.69 | 0.99 | 4.63 | 4.22 | -2.00 | -13.93 | 4.22 | -8.45 | -10.11% |
| 2019 | 13.27 | 3.46 | -0.54 | -4.84 | -4.71 | 9.42 | -2.29 | -2.34 | -4.19 | 10.53 | 11.85 | 2.47 | +33.93% |
| 2020 | -5.17 | -1.12 | -4.99 | 12.89 | 9.37 | 1.42 | -2.84 | 0.94 | 0.78 | -2.79 | 9.82 | 3.08 | +21.34% |
| 2021 | 1.90 | -2.51 | -4.18 | 2.81 | -2.18 | 6.45 | -1.37 | 4.00 | -4.15 | 0.25 | -4.29 | 2.37 | -1.59% |
| 2022 | -10.77 | -1.96 | 5.73 | -7.54 | -3.35 | 3.08 | 4.65 | 1.14 | -1.90 | 7.00 | 6.18 | -2.79 | -2.30% |
| 2023 | 3.02 | -5.67 | 0.45 | 2.29 | -1.19 | 1.26 | -0.13 | -0.15 | -4.28 | -6.10 | 5.99 | 13.49 | +7.70% |
| 2024 | 1.35 | 1.37 | 0.07 | -6.11 | 4.14 | 5.42 | 6.46 | 1.64 | -2.30 | -1.62 | 0.44 | -6.97 | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 17.39% | 18.84% | 17.78% | 20.42% | 22.80% |
| Sharpe ratio | 0.01 | -0.13 | 0.20 | -0.02 | 0.11 |
| Best month | +13.49% | +6.46% | +13.49% | +13.49% | +13.49% |
| Worst month | -6.97% | -6.97% | -6.97% | -10.77% | -10.77% |
| Maximum loss | -11.75% | -11.75% | -11.75% | -25.03% | -30.61% |
| Outperformance | -1.00% | - | -1.80% | +3.49% | - |
All quotes in USD
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,056.9700 | +4.45% | -0.19% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,332.3101 | +12.57% | +16.86% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,470.9299 | +7.98% | +12.96% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,873.3500 | +7.47% | +11.49% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 231.7000 | +12.43% | +17.20% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 366.8000 | +8.82% | +16.59% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 343.6800 | +13.47% | +20.37% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 198.8500 | +2.54% | -2.25% | |
| Candriam Equities L Biotechnolog... | reinvestment | 148.9200 | - | - | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,679.7100 | +6.38% | +7.41% | |
| Candriam Equities L Biotechnolog... | reinvestment | 2,077.2100 | +6.48% | +7.79% | |
| Candriam Equities L Biotech.N US... | reinvestment | 603.8700 | +5.88% | +6.62% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 197.1100 | +4.34% | +0.20% | |
| Candriam Equities L Biotech.R US... | reinvestment | 271.2000 | +7.22% | +10.68% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 206.5400 | +5.22% | +2.73% | |
| Candriam Equities L Biotechnolog... | reinvestment | 849.4700 | +6.27% | +7.90% | |
| Candriam Equities L Biotechnolog... | paying dividend | 775.6700 | +6.23% | +7.80% |
Performance
| YTD | +2.99% | ||
|---|---|---|---|
| 6 Months | +0.23% | ||
| 1 Year | +6.48% | ||
| 3 Years | +7.79% | ||
| 5 Years | +29.67% | ||
| 10 Years | - | ||
| Since start | +107.72% | ||
| Year | |||
| 2023 | +7.70% | ||
| 2022 | -2.30% | ||
| 2021 | -1.59% | ||
| 2020 | +21.34% | ||
| 2019 | +33.93% | ||
| 2018 | -10.11% | ||
| 2017 | +26.78% | ||
